1. Home
  2. CPIX vs CIGL Comparison

CPIX vs CIGL Comparison

Compare CPIX & CIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$3.85

Market Cap

59.5M

Sector

Health Care

ML Signal

HOLD

CIGL

Concorde International Group Ltd Class A Ordinary Shares

SELL

Current Price

$2.21

Market Cap

59.4M

ML Signal

SELL

Company Overview

Basic Information
Metric
CPIX
CIGL
Founded
1999
1997
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
59.4M
IPO Year
2009
2025

Fundamental Metrics

Financial Performance
Metric
CPIX
CIGL
Price
$3.85
$2.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
230.6K
901.9K
Earning Date
03-03-2026
09-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$41,278,349.00
$11,072,733.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.21
6.32
52 Week Low
$1.85
$1.40
52 Week High
$7.25
$31.06

Technical Indicators

Market Signals
Indicator
CPIX
CIGL
Relative Strength Index (RSI) 47.43 52.90
Support Level $3.54 $1.85
Resistance Level $3.98 $2.65
Average True Range (ATR) 0.34 0.30
MACD -0.07 0.02
Stochastic Oscillator 22.73 19.89

Price Performance

Historical Comparison
CPIX
CIGL

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About CIGL Concorde International Group Ltd Class A Ordinary Shares

Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.

Share on Social Networks: